A randomised, controlled trial to compare the effects of systemic HRT [hormone replacement therapy] (tibolone) and vaginal oestrogen (estring) [estradiol] upon the overactive bladder in postmenopausal women
Phase of Trial: Phase III
Latest Information Update: 15 Jan 2018
At a glance
- Drugs Estradiol (Primary) ; Tibolone (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 10 Jul 2009 Actual end date (Sep 2005) added as reported by ISRCTN: Current Controlled Trials.
- 19 Aug 2006 New trial record.